Tag: Viking Therapeutics

Shares of Viking Therapeutics gained approximately 2.9% to $36.42 following a pivotal regulatory decision that is reshaping the market for ...

A prominent analyst at investment bank H.C. Wainwright has reiterated a bullish stance on Viking Therapeutics, setting a price target ...

The competitive landscape for obesity treatments is heating up, fueling speculation about potential industry consolidation. At the center of this ...

Shares of Viking Therapeutics are currently trading within a narrow band between $35 and $36, continuing a period of consolidation ...

A prominent financial publication's recent endorsement has refocused investor attention on Viking Therapeutics and its potential trajectory through 2026. The ...

Shares of Viking Therapeutics are currently navigating a challenging technical landscape. Market experts continue to highlight significant long-term potential driven ...

Viking Therapeutics, a clinical-stage biopharmaceutical company, captured significant investor interest this week following its presentation at the Piper Sandler Healthcare ...

The shares of Viking Therapeutics have delivered a remarkable 34% gain over the past three months, signaling a powerful resurgence. ...

The pharmaceutical landscape for weight-loss treatments is witnessing a dramatic confrontation. As industry titans engage in a fierce price war, ...

As U.S. markets operated on a shortened post-Thanksgiving schedule, research departments remained active, with Viking Therapeutics generating significant analyst enthusiasm. ...